Carregant...
Intravenous immunoglobulin replacement treatment reduces in vivo elastase secretion in patients with common variable immune disorders
BACKGROUND: Intravenous immunoglobulin (IVIg) treatment partially replaces antibody defects and modulates innate and adaptive immune cells in patients with primary antibody deficiencies. MATERIALS AND METHODS: This study was focused on the evaluation of the effects of in vivo IVIg administration on...
Guardat en:
| Publicat a: | Blood Transfus |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Edizioni SIMTI - SIMTI Servizi Srl
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6476744/ https://ncbi.nlm.nih.gov/pubmed/30036181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2018.0043-18 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|